Creabilis Appoints Dr. Eliot Forster as its New Chief Executive Officer

04-Oct-2010 - Creabilis SA announced the appointment of Eliot Forster as its new Chief Executive Officer. Dr Forster brings to Creabilis significant drug development experience having brought a number of molecules to market. Dr Forster has close to 20 years industry experience in biotechnology and ...

Creabilis Appoints George F. Horner III as its Chairman

16-Sep-2010 - Creabilis SA announced the appointment of George F. Horner III as its Chairman. Mr Horner brings to Creabilis an unrivalled track record in building successful biotech businesses that have generated significant value for their shareholders. Mr Horner has over 40 years industry experience gained ...

Creabilis Therapeutics Appoints Anthony Wilson as its New Chief Executive Officer

18-Jun-2008 - Creabilis Therapeutics SpA announced the appointment of Tony Wilson as Chief Executive Officer with immediate effect. Mr Wilson brings to Creabilis a broad knowledge of the biotechnology and pharmaceutical industry combined with first hand experience of the dermatology sector. He has over 25 ...

Creabilis therapeutics SpA appoints Domenico Criscuolo as Chief Medical Officer

12-Mar-2007 - Creabilis therapeutics SpA announced the appointment of Domenico Criscuolo as Chief Medical Officer, effective February 21st, 2007. Dr Criscuolo graduated in Medicine at the University of Rome and got a PhD in Haematology and another one in Clinical Oncology. He started working as Clinical ...

Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration

Improvement of HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies

15-Nov-2006 - Nautilus Biotech SA and Creabilis Therapeutics SpA have announced that they have shown increased biological activity and resistance to proteolysis in vitro of the High Mobility Group Box One (HMGB1) Box A protein, an important technical milestone in their collaboration to identify a potential ...